Akadeum Life Sciences
Ann Arbor, US · Founded 2014 · Delaware corporation · 13 known investors
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical Devicesin /akadeum-life-sciences-inc-@akadeum
Founders & leadership
JS
Jeffrey S. WilliamsDirector
BM
Brandon McNaughtonExecutive Officer, Director
JM
James MilitelloExecutive Officer
KH
Kalyan HandiqueExecutive Officer, Director
DN
Douglas NealDirector
JY
John YoungerExecutive Officer, Director
PD
Paul D'AmatoDirector
DK
Dan KidleDirector
JL
Jenni LiDirector
Investors · 13
Arboretum VenturesAnn Arbor · $5M – $15M
BeringeaLondon · $3M – $10M
Berkeley CatalystBerkeley
BlueStone Venture PartnersTucson · $250K – $1M
eLab VenturesAnn Arbor · $25K – $100K
ID VenturesDetroit · $50K – $250K
Invest MichiganNorthville · $100K – $250K
Kern Venture GroupBakersfield
Michigan Capital NetworkGrand Rapidsvia Jenni Li · board
Michigan RiseEast Lansing · $50K – $150K
NYBC VenturesNew York
Western Technology InvestmentPortola Valley · $250K – $30M
NYBC Venturesreported
Reported raises · per SEC filings
Form D private placements▶$2.1MraisedJul 2026 · 9 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kalyan HandiqueExecutive Officer, Director
- Paul D'AmatoDirector
- Jenni LiDirector
- James MilitelloExecutive Officer
- Offering amount
- $3.4M
- Amount sold
- $2.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedApr 2025 · 35 investors · BiotechnologyRule 506(b)
▶$5.6MraisedApr 2025 · 35 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey S. WilliamsDirector
- Paul D'AmatoDirector
- Dan KidleDirector
- Brandon McNaughtonExecutive Officer, Director
- James MilitelloExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $5.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMay 2023 · 22 investors · BiotechnologyRule 506(b)
▶$6MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HyunDirector
- Brandon McNaughtonExecutive Officer, Director
- Dan KidleDirector
- George DunbarDirector
- John GavenonisDirector
- Offering amount
- $6.5M
- Amount sold
- $6M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · Other Health CareRule 506(b)
▶$900KraisedNov 2018 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon McNaughtonExecutive Officer, Director
- John YoungerExecutive Officer, Director
- Brock SiegelDirector
- Douglas NealDirector
- Offering amount
- $2M
- Amount sold
- $900K
- Minimum investment
- $25K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MraisedAug 2017 · 19 investors · Other Health CareRule 506(b)
▶$1.5MraisedAug 2017 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul BrownDirector
- John YoungerExecutive Officer, Director
- Brandon McNaughtonExecutive Officer, Director
- William WoodDirector
- Douglas NealDirector
- Offering amount
- $1.6M
- Amount sold
- $1.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$360KraisedDec 2016 · Other Health CareRule 506(b)
▶$360KraisedDec 2016 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John YoungerExecutive Officer, Director
- Douglas NealDirector
- Brandon McNaughtonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $360K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$905.1KraisedAug 2015 · 3 investors · Other Health CareRule 506(b)
▶$905.1KraisedAug 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon McNaughtonExecutive Officer, Director
- Douglas NealDirector
- John YoungerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $905.1K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Akadeum secures $20m to advance cell separation platformbioprocessintl.com · 2025
- Akadeum Life Sciences Lands Major Investment to Fuel Growth in Cell and Gene Therapy - BioSpacebiospace.com · 2025
- Akadeum Life Sciences Raises $20M+ in Fundingfinsmes.com · 2025
- Akadeum Raises $17.5M Financing Round Led by Arboretum Venturesakadeum.com · 2021
- Akadeum Series A Funding Round - Akadeum Life Sciencesakadeum.com · 2019